CompaniesByCap
MRKR
Marker Therapeutics, Inc. (MRKR)
NASDAQ · Healthcare

Marker Therapeutics, Inc. Income Statement 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenues
Revenue3.5M6.6M3.3M3.5M0500,000213,194205,994183,064
Gross Profit
Profitability
Operating Income-12.9M-11.1M-14.6M-19.8M-39.5M-28.9M-22.5M-148.2M-11.5M
EBITDA
Net Income-12.2M-10.7M-8.2M-29.9M-41.9M-28.7M-21.4M-148.0M-11.0M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)15M9M9M8M8M47M46M45M9M

Marker Therapeutics, Inc. Income Statement — FAQ

Marker Therapeutics, Inc. (MRKR) income statement over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MRKR's income statement history?

The chart and table above show Marker Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.